CareDx Balance Sheet Health

Financial Health criteria checks 6/6

CareDx has a total shareholder equity of $273.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $477.0M and $203.7M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$240.85m
EquityUS$273.25m
Total liabilitiesUS$203.74m
Total assetsUS$476.99m

Recent financial health updates

No updates

Recent updates

CareDx: Too Risky For Me

Dec 30

The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 26%

Nov 05
The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 26%

CareDx Resolves Key Issues: Poised For Growth In Transplant Diagnostics

Sep 29

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Aug 01
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

CareDx: Benefiting From Some Certainty

Jul 15

Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge

Apr 27
Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Mar 02
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry

Dec 27
CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry

CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Dec 27
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price

Jun 29
Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price

Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)

May 16
Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)

CareDx: Shaking Off First-Mover Disadvantage

Oct 18

CareDx: Best Near Cap-Gain Health Diagnostics Prospect Say Market Makers

Aug 08

Financial Position Analysis

Short Term Liabilities: CDNA's short term assets ($334.1M) exceed its short term liabilities ($81.4M).

Long Term Liabilities: CDNA's short term assets ($334.1M) exceed its long term liabilities ($122.3M).


Debt to Equity History and Analysis

Debt Level: CDNA is debt free.

Reducing Debt: CDNA had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable CDNA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: CDNA is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 22.2% per year.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 12:16
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CareDx, Inc is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroBTIG
William BonelloCraig-Hallum Capital Group LLC
Matthew SykesGoldman Sachs